NeuExcell strikes deal with Fujifilm for stroke gene therapy; J&J expands in Ireland
In an effort to advance a gene therapy to treat ischemic cortical stroke, Fujifilm Diosynth Biotechnologies and NeuExcell Therapeutics have reached an
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
